19 June 2013
Keywords: dor, gets, 3m, part, potential, orbec, deal
Article | 15 January 2007
Florida, USA-based biopharmaceutical company DOR BioPharma says it has received $3.0 million as part of a non-binding letter of intent from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 2007
18 June 2013
© 2013 thepharmaletter.com